High Content Screening for Physiological Endpoints in the Development of an RNA Therapeutic for Heart FailureWednesday, 14 May 2014 at 15:00 Add to Calendar ▼2014-05-14 15:00:002014-05-14 16:00:00Europe/LondonHigh Content Screening for Physiological Endpoints in the Development of an RNA Therapeutic for Heart Failure High Content Analysis in Barcelona, SpainBarcelona, SpainSELECTBIOenquiries@selectbiosciences.com High content screening of contractile calcium transients was used to identify microRNAs that suppress cardiomyocyte contractility. An antisense RNA targeting one of the microRNAs halted the progression of established heart failure in a mouse model. |